Safety evaluation of a new formulation of intravenous ofloxacin.
Stein
G E
GE
Department of Medicine, Michigan State University, East Lansing, USA.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage* / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015242:Ofloxacin